Physical training decreases plasma thrombomodulin in Type I and Type II diabetic patients

Diabetologia

Volumn 44, Issue 6, 2001, Pages 693-699

  Rigla, M ^a   Fontcuberta, J ^a   Mateo, J ^a   Caixas A ^a   Pou, J M ^a   De Leiva, A ^a   Perez A ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Endothelial markers; Exercise; Thrombomodulin; Tissue factor pathway inhibitor; Training

Indexed keywords

HEMOGLOBIN A1C; PLASMINOGEN ACTIVATOR INHIBITOR; THROMBOMODULIN; TISSUE FACTOR PATHWAY INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; EXERCISE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM;

ADOLESCENT; ADULT; ANTHROPOMETRY; BIOLOGICAL MARKERS; BLOOD COAGULATION; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; EXERCISE; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; PHYSICAL EDUCATION AND TRAINING; PHYSICAL FITNESS; THROMBOMODULIN;

EID: 0034847716     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051677     Document Type: Article

References (52)

1. Endothelium and regulation of coagulation
2. Levels of plasma thrombomodulin are increased in atheromatous arterial disease
3. Factor VII and extrinsic pathway inhibitor in acute coronary disease
4. Factor VIII complex and endothelial damage
5. The status of PAI-1 as a risk factor for arterial and thrombotic disease: A review
6. Von Willebrand factor and development of diabetic nephropathy in IDDM
7. Coagulation and fibrinolytic system impairment in insulin-dependent diabetes mellitus
8. Elevation of plasma thrombomodulin level in diabetic patients with early diabetic nephropathy
9. Increased soluble fibrin monomer and soluble thrombomodulin levels in non-insulin-dependent diabetes mellitus
10. Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria
11. Thrombogenic factors are related to urinary albumin excretion rate in Type I (insulin-dependent) and Type II (non-insulin-dependent) diabetic patients
12. Normalisation of tissue factor pathway inhibitor activity after glycaemic control optimisation in type 1 diabetic patients
13. Lipids and endurance physical activity
14. The relationship of physical fitness to lipid and lipoprotein (a) levels in adolescents with IDDM
15. Effect of physical exercise on lipoprotein (a) and LDL modifications in type 1 and type 2 diabetic patients
16. Effect of exercise on coronary endothelial function in patients with coronary artery disease
17. Diabetes mellitus and exercise
18. Compendium of physical activities: Classification of energy cost of human physical activities
19. Design and validation of a new immunoassay for soluble forms of thrombomodulin and studies on plasma
20. A sensitive assay of extrinsic coagulation pathway inhibitor in plasma and plasma fractions
21. Thrombomodulin and induced tissue factor expression on monocytes as markers of diabetic microangiopathy: A prospective study on hemostasis and lipoproteins in insulin-dependent diabetes mellitus
22. Increased tissue factor pathway inhibitor (TFPI) and coagulation in patients with insulin-dependent diabetes mellitus
23. Thrombomodulin levels in insulin-dependent diabetic patients with microalbuminuria
24. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM
25. Increased thrombomodulin values in plasma of diabetic men with microangiopathy
26. Plasma thrombomodulin concentration in diabetes mellitus
27. Protein C activation in NIDDM patients
28. Clinical significance of urinary and serum thrombomodulins in patients with non-insulin-dependent diabetes mellitus
29. Elevated serum and urinary thrombomodulin levels in patients with non-insulin-dependent diabetes mellitus
30. Mechanisms of elevation of serum and urinary concentrations of soluble thrombomodulin in diabetic patients: Possible applications as a marker for vascular endothelial injury
31. Soluble thrombomudulin antigen in conditioned medium is increased by damage of endothelial cells
32. Plasma thrombomodulin concentrations in relation to cardiovascular risk factors in a population sample
33. Circulating thrombomodulin as a novel endothelial cell marker: Comparison of its behavior with von Willebrand factor and tissue-type plasminogen activator
34. Exercise training increases basal nitric oxide production from the forearm in hypercholesterolemic patients
35. Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects: Role of the endothelium-derived nitric oxide
36. Physical training improves flow-mediated dilation in patients with the poly-metabolic syndrome
37. Correction of endothelial dysfunction in chronic heart failure: Additional effects of exercise training and oral L-arginine supplementation
38. Cardiovascular effects of exercise: Role of endothelial shear stress
39. Coagulation and thrombomodulin in response to exercise of different type and duration
40. Effects of salicylic acid and cilostazol administration on serum thrombomodulin concentration in diabetic patients
41. Influence of angiotensin-converting enzyme inhibitor enalaprilat on endothelial-derived substances in the critically ill
42. Lifestyle and hemostatic risk factors for ischemic heart disease: The Caerphilly Study
43. New antithrombotic agents
44. Strenuous exercise, plasma fibrinogen and factor VII activity
45. Effect of endurance training and seasonal fluctuation on coagulation and fibrinolysis in young sedentary men
46. Impaired fibrinolytic response to exercise in type II diabetes: Effects of exercise and physical training
47. Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old adults
48. Influence of a rehabilitation sports programme on the fibrinolytic activity of patients after myocardial infarction
49. Effect of physical exercise on blood clotting and fibrinolysis
50. Prolonges endurance exercise and blood coagulation: A 9 month prospective study
51. Fibrinolytic system during long-distance running in IDDM patients and in healthy subjects
52. Hemostatic alterations with exercise conditioning in NIDDM